SEC Form 4 research
| Issuer | Maze Therapeutics, Inc. |
|---|---|
| Tickers | MAZE |
| Reporting owners | 36 |
| Officers and directors | 7 |
| Last public filing | 2026-11-04 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-11-02 | Coloma Jason V | S | 5,345 | $31.05 | Not reported |
| 2026-11-04 | 2026-11-02 | Coloma Jason V | S | 26,563 | $30.1 | Not reported |
| 2026-11-04 | 2026-11-02 | Coloma Jason V | S | 336 | $30.91 | Not reported |
| 2026-11-04 | 2026-11-02 | Coloma Jason V | S | 2,257 | $30.12 | Not reported |
| 2026-10-30 | 2026-10-29 | Dandekar Atul | S | 7,500 | $32.07 | Not reported |
| 2026-10-02 | 2026-10-01 | Coloma Jason V | S | 31,908 | $27.02 | Not reported |
| 2026-10-02 | 2026-10-01 | Coloma Jason V | S | 2,593 | $27.02 | Not reported |
| 2026-10-02 | 2026-10-01 | Bernstein Harold | S | 16,141 | $26.93 | Not reported |
| 2026-10-01 | 2026-09-29 | Dandekar Atul | S | 7,500 | $27.06 | Not reported |
| 2026-09-08 | 2026-09-04 | Bernstein Harold | S | 9,705 | $26.22 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.